Lupin
Lupin shares to be in focus on Thursday as USFDA approves Dapagliflozin and Metformin tablets
Lupin's shares are expected to attract investor attention as the company received U.S. FDA approval for Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets.
1 min read8 Apr 2026Desh Bandhu Gupta’s masterplan to rebuild the pharma giant Lupin
After struggling through the 1990s, Desh Bandhu Gupta, founder of pharma company Lupin, set out a clear strategy for growth that would outlast him
5 min read16 Feb 2026When Dilip Shanghvi, Yusuf Hamied, Vinita Gupta, GV Prasad, other doyens discussed the future of Indian Pharma
The occasion was the launch of Made in India, a biography of Lupin's late founder Desh Bandhu Gupta, chronicling his life and, through it, the rise of the Indian pharmaceutical industry itself.
5 min read10 Feb 2026Obesity drugs may spur licensing, distribution deals for Indian drugmakers after patent expires
The rising demand for obesity drugs is prompting Indian pharma firms to pursue licensing and distribution partnerships, particularly for GLP-1 drugs. Major deals have been signed, with analysts predicting continued growth in the market as patents expire and supply chain collaborations emerge.
3 min read2 Jan 2026Bharat Dynamics to TCS - Jay Thakkar suggests three stocks to buy or sell for short-term in F&O segment
Nifty 50 and Sensex rose on Wednesday amid optimism over U.S.-India trade talks and expectations of an interest rate cut. Nifty 50 increased by 0.49% to 24,991.25, while Sensex gained 0.5% to 81,506.04. Analysts suggest potential bounce backs for certain stocks including Bharat Dynamics and TCS.
4 min read10 Sep 2025Now Sun Pharma, Lupin work on anti-obesity pill to cut costs, address jab aversion
Sun Pharma and Lupin pursue regulatory approval for oral weight-loss drugs, potentially reshaping treatment access.
3 min read8 Sep 2025Ajanta Pharma, Lupin to Sun Pharma: Why are pharma stocks falling despite Trump’s tariff exemption?
Ajanta Pharma, Gland Pharma, Lupin, Aurobindo Pharma, Sun Pharmaceutical Industries, Zydus Lifesciences, Divi's Laboratories and Torrent Pharmaceuticals were among the top losers in the Nifty Pharma index, which shed over 1% during the session.
2 min read28 Aug 2025F&O Strategy: UNO Minda to Lupin — Rupak De suggests buy or sell strategy for THESE stocks - 25 August 2025
Indian stock market opened positively as Nifty 50 rose 0.28% and BSE Sensex increased by 0.29%. The market sentiment improved following hints from the U.S. Federal Reserve about potential interest rate cuts, benefiting emerging markets like India.
2 min read25 Aug 2025Q1 results today: Concor, Airtel, Britannia, Lupin, Castrol India, Adani Ports, Eveready earnings on August 5
Q1 results on August 5: Concor, Airtel, Britannia, Lupin, Castrol India, Adani Ports and Eveready Industries among 147 companies to release their earnings report today.
2 min read5 Aug 2025